Biocomposites Acquires Remaining Shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L.

Solabia Acquires Mibelle Biochemistry, Seqens' Botanical Actives and IVD Activity, and Xebios Group

March 5, 2026

Biotechnology

Solabia, a Paris-headquartered biotech platform focused on natural active ingredients and diagnostics solutions, has agreed to acquire three complementary businesses as part of its international expansion strategy. The acquisitions include Switzerland-based Mibelle Biochemistry, France-based Seqens' Botanical Actives and In-Vitro Diagnostics activity, and Germany/Netherlands-based Xebios Group.

Surmodics Merges with Biocoat; Forms Surmodics Services & Technologies Division

December 10, 2025

Medical Devices

Surmodics has completed a merger with Biocoat and formed a new division, Surmodics Services & Technologies (SST), to carry forward the portion of Biocoat's business remaining after divesting certain assets. SST, based in Horsham, Pennsylvania, will provide hydrophilic coating technologies, custom polymer formulations and full-service coating operations to medical device manufacturers worldwide.

HAS Healthcare Advanced Synthesis Acquires Cerbios-Pharma to Form Leading CDMO Group

March 31, 2025

Healthcare Services

HAS Healthcare Advanced Synthesis SA (HAS) announced the planned acquisition of Cerbios-Pharma SA (Cerbios) to create a leading international CDMO group in Switzerland’s Ticino region. The combination brings complementary expertise in production, chemistry and biology, enabling expanded development and manufacturing services (including ADC-related capabilities), supported by 65 Equity Partners.

Biosynth Acquires celares to Expand Bioconjugation and Polymer Drug Delivery Capabilities

July 11, 2023

Biotechnology

Biosynth, a Switzerland-based supplier of critical raw materials and manufacturing services, acquired Berlin-based celares, a developer and manufacturer of bioconjugates, activated PEGs and polymer-based drug delivery excipients. The acquisition strengthens Biosynth's capabilities in conjugate vaccines and bioconjugate drugs and adds GMP bioconjugation and PEGylation manufacturing in Berlin to its service offering.

Biocomposites Takes Minority Stake in Renovos Biologics

July 5, 2023

Biotechnology

Biocomposites has taken a minority equity stake in Renovos Biologics to support development and pre-market approval of the RENOVITE nanoclay therapeutic delivery platform. The investment will give Renovos access to Biocomposites' development expertise and global distribution network; Biocomposites CEO Michael Harris will join Renovos' board.

LabVantage Solutions and Biomax Informatics Merge

October 11, 2022

Software

LabVantage Solutions and Germany-based Biomax Informatics have closed a merger agreement to combine their laboratory informatics, knowledge-management and semantic-search capabilities. The combination brings together LabVantage’s LIMS/ELN/SDMS platform with Biomax’s decision-support and knowledge-management software to expand product and service offerings for life sciences, biomanufacturing and healthcare customers.